Author:
Sánchez Yordank,Noa Enrique,Alfonso Wilma,Dubed Marta,Álvarez Giselle,Navea Leonor,Montes de Oca Nivian,Lobaina Leonor,Díaz Elaine
Subject
Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Reference37 articles.
1. Note for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal viruses;Committee for Proprietary Medicinal Products (CPMP),1996
2. Pathogen safety of plasma-derived products – Haemate® P/Humate-P®;Gröner;Haemophilia,2008
3. La sécurité virale des médicaments d'origine biologique;Barin;Ann Pharm Fr,2008
4. Validation of model virus removal and inactivation capacity of an erythropoietin purification process;Pérez;Biologicals,2011
5. Q4B Annex 4C. Microbiological examination of non-sterile products: acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use;ICH,2008